Skip to content
akaturk Academic measurement
For academics Sign in Sign up

Article detail · 2025

Indomethacin-encapsulated PLGA nanoparticles improve therapeutic efficacy by increasing apoptosis and reducing motility in glioblastoma cells

YÖKSİS OpenAlex SJR Q2 JCR Q2 Citations 2 Percentile 49.5% FWCI 0.24
Year
2025
Type
article

Data source split

  • YÖKSİS YÖKSİS article record
  • YÖKSİS venue Pharmaceutical Development and Technology
  • Catalog match (ISSN) Pharmaceutical Development and Technology
  • OpenAlex OpenAlex enrichment (abstract, citations, topics)

Abstract

OpenAlex · English

Glioblastoma, with a low survival rate, is an aggressive and difficult-to-treat lethal type of brain cancer. Indomethacin (IND), a non-steroidal anti-inflammatory drug, has antitumoral activity in many cancers, including gliomas. However, its poor aqueous solubility is a critical issue. Nanomaterials are crucial tools for overcoming solubility problems and facilitating drug delivery. Herein, a polymeric nanoparticle system, poly(lactic-co-glycolic acid) (PLGA) was used to encapsulate IND. Although PLGA is an FDA-approved copolymer for drug delivery, no trials with IND-loaded PLGA-NPs have been conducted to treat brain tumors. Encapsulation success was revealed by DLS, zeta potential, TEM, and FTIR analysis; IND/PLGA-NPs had nanoscale particle size (160.6 nm), narrow size distribution (0.230, PDI), and good stability (−23.9 mV). Fluorescence imaging showed that PLGA-NPs can penetrate U-87MG cells. Short-term/one-hour treatment with bound-IND increased the free-IND effect in gliomas by ⁓10 times/48h and 12.39 times/72h. Even against long-term exposure to IND, IND/PLGA-NP treatment revealed a highly marked result; the IC50 value of bound-IND (treatment-time:1h, analysis at 48h) was ∼200µM, IC50 value of free-IND (treatment-time:48h) was ∼390µM. Furthermore, IND/PLGA-NPs’ anticancer activity (100 µM of IND/1h, analysis at 48h) was also supported by induced apoptosis and reduced migration/colony formation in glioma cells. All evidence suggests that IND/PLGA-NPs may be a potentially promising agent for treating gliomas.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

2 citations

OpenAlex cited_by_count (cache / database)

Authors

  1. FERHAT BOSTANCI İSTANBUL SABAHATTİN ZAİM ÜNİVERSİTESİ
  2. ASLIHAN ŞENGELEN
  3. Yunus Aksüt
  4. EREN YILDIRIM İSTANBUL ÜNİVERSİTESİ-CERRAHPAŞA
  5. İREM ÖĞÜTÇÜ
  6. OĞUZ YÜCEL İSTANBUL ÜNİVERSİTESİ-CERRAHPAŞA
  7. SERKAN EMİK
  8. GÜLTEN GÜRDAĞ İSTANBUL ÜNİVERSİTESİ-CERRAHPAŞA
  9. MURAT PEKMEZ